Intravenous bisphosphonate treatment and osteonecrosis of the jaw in patients with cancer: wide CIs, Yule-Simpson and King Kong effects, and no therapeutic outcomes.
Ivo
I
Abraham
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced / Q000209:etiology*; D009369:Neoplasms / Q000150:complications*; D016017:Odds Ratio; D010020:Osteonecrosis / Q000139:chemically induced / Q000209:etiology*; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates